Could vascular endothelial growth factor inhibitors induce hidradenitis suppurativa? Report of three patients with renal cancer treated with sunitinib

Dermatol Ther. 2020 May;33(3):e13306. doi: 10.1111/dth.13306. Epub 2020 Apr 7.

Authors

Trinidad Montero-Vilchez¹, Ahinoa Bueno-Rodriguez¹, Luis Salvador-Rodriguez¹, Salvador Arias-Santiago^{1

2}, Alejandro Molina-Leyva^{1

2

3

4}

Affiliations

¹ Dermatology Department, Hidradenitis Suppurativa Clinic, Hospital Universitario Virgen de las Nieves, Granada, Spain.
² Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain.
³ Dermatology Department, University of Granada, Granada, Spain.
⁴ European Hidradenitis Suppurativa Foundation (EHSF), Dessau-Roßlau, Germany.

PMID: 32181974
DOI: 10.1111/dth.13306

No abstract available

Publication types

Letter

MeSH terms

Hidradenitis Suppurativa* / chemically induced
Hidradenitis Suppurativa* / drug therapy
Humans
Kidney Neoplasms* / drug therapy
Sunitinib
Vascular Endothelial Growth Factor A

Substances

Vascular Endothelial Growth Factor A
Sunitinib